Telemedicine in cystic fibrosis

Cystic Fibrosis (CF) requires lifetime multidisciplinary care to manage both pulmonary and extra pulmonary manifestations. The median age of survival for people with CF is rising and the number of adults with CF is expected to increase dramatically over the coming years. People with CF have better o...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical & translational endocrinology 2021-12, Vol.26, p.100270-100270, Article 100270
Main Authors: Desimone, Marisa E., Sherwood, Jordan, Soltman, Sarah C., Moran, Antoinette
Format: Article
Language:English
Subjects:
Cystic fibrosis
Cystic fibrosis related diabetes
Special Issue: CF Endocrinology Advance
Telehealth
Telemedicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cystic Fibrosis (CF) requires lifetime multidisciplinary care to manage both pulmonary and extra pulmonary manifestations. The median age of survival for people with CF is rising and the number of adults with CF is expected to increase dramatically over the coming years. People with CF have better outcomes when managed in specialty centers, however access can be limited. Telemedicine and technology-based care solutions may help to overcome barriers to availability and improve access. This review outlines the use of telehealth for CF management. Telehealth has been utilized for CF across a broad variety of indications, even prior to the COVID-19 pandemic, and in general has been well accepted by patients and providers. There are a paucity of data, however, related to health outcomes, and the healthcare utilization specific to CF and its related comorbidities. Future studies are needed to address the questions of health outcomes, cost, burdens of telehealth and barriers to implementation.
ISSN:2214-6237
2214-6237
DOI:10.1016/j.jcte.2021.100270